We are live on ! Find out more
PIM

Partner Investment Management Portfolio holdings

AUM $13.9M
1-Year Est. Return 55.92%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
+55.92%
3 Year Est. Return
+168.07%
5 Year Est. Return
+301.91%
10 Year Est. Return
–
AUM
$86.8M
AUM Growth
-$18.6M
Cap. Flow
-$21.3M
Cap. Flow %
-24.54%
Top 10 Hldgs %
34.84%
Holding
103
New
20
Increased
22
Reduced
25
Closed
29

Top Buys

Rank Stock Value
1
ALNA
Allena Pharmaceuticals
ALNA
+$7.09M
2
BIDU icon
Baidu
BIDU
+$2.46M
3
ZBH icon
Zimmer Biomet
ZBH
+$1.67M
4
CME icon
CME Group
CME
+$1.46M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.44M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$2.37M
2
JD icon
JD.com
JD
+$1.84M
3
ELV icon
Elevance Health
ELV
+$1.77M
4
AGN.PRA
Allergan plc
AGN.PRA
+$1.76M
5
CNC icon
Centene
CNC
+$1.61M

Sector Composition

Rank Sector Weight
1 Healthcare 49.46%
2 Technology 16.05%
3 Communication Services 4.89%
4 Financials 3.92%
5 Consumer Discretionary 3.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JD icon
76
JD.com
JD
$44.5B
– –
-48,124
Closed -$1.84M
HAPN
77
Happen Inc
HAPN
$2.36B
– –
-7,655
Closed -$233K
MDXG icon
78
PUT
MiMedx Group
MDXG
$622M
– –
-11,500
Closed -$137K
META icon
79
CALL
Meta Platforms (Facebook)
META
$1.5T
– –
-5,300
Closed -$906K
META icon
80
Meta Platforms (Facebook)
META
$1.5T
– –
-13,853
Closed -$2.37M
MOH icon
81
CALL
Molina Healthcare
MOH
$10.2B
– –
-9,700
Closed -$667K
NTES icon
82
NetEase
NTES
$84.2B
– –
-15,160
Closed -$800K
PANW icon
83
Palo Alto Networks
PANW
$299B
– –
-37,944
Closed -$911K
PFE icon
84
CALL
Pfizer
PFE
$145B
– –
-120,367
Closed -$4.08M
PFE icon
85
Pfizer
PFE
$145B
– –
-32,738
Closed -$1.11M
SPGI icon
86
S&P Global
SPGI
$123B
– –
-5,237
Closed -$819K
SPY icon
87
State Street SPDR S&P 500 ETF Trust
SPY
$821B
– –
-4,832
Closed -$1.21M
SWKS icon
88
Skyworks Solutions
SWKS
$9.22B
– –
-4,721
Closed -$481K
V icon
89
Visa
V
$690B
– –
-4,502
Closed -$474K
VMC icon
90
Vulcan Materials
VMC
$36.7B
– –
-2,488
Closed -$298K
VYGR icon
91
Voyager Therapeutics
VYGR
$181M
– –
-4,844
Closed -$100K
XBI icon
92
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.92B
– –
-39,300
Closed -$3.4M
XBI icon
93
State Street SPDR S&P Biotech ETF
XBI
$9.92B
– –
-10,792
Closed -$904K
CLVS
94
DELISTED
Clovis Oncology, Inc.
CLVS
– –
-4,053
Closed -$334K
XENT
95
DELISTED
Intersect ENT, Inc
XENT
– –
-9,913
Closed -$309K
PRAH
96
DELISTED
PRA Health Sciences, Inc.
PRAH
– –
-1,865
Closed -$142K
AGN.PRA
97
DELISTED
Allergan plc
AGN.PRA
– –
-2,383
Closed -$1.76M
KITE
98
DELISTED
Kite Pharma, Inc.
KITE
– –
-79
Closed -$14K
1 2 3
4

Similar funds

SWM
Sequoia Wealth Management Hoffman Estates, Illinois $12.9M AUM 25.75% 1-Year Est. Return
ACM
ADI Capital Management New York $17.5M AUM 49.32% 1-Year Est. Return
ECAU
Everett Capital Advisors (UK) London, United Kingdom $18.6M AUM 22.81% 1-Year Est. Return
SL
Signition LP New York $20M AUM 28.26% 1-Year Est. Return
DII
Domini Impact Investments New York $7.59M AUM 47.68% 1-Year Est. Return
FIM
FourPoints Investment Managers Paris, France $21.1M AUM 11.11% 1-Year Est. Return
EM
Emancipation Management New York $22.4M AUM 18.33% 1-Year Est. Return
BHC
Balch Hill Capital San Francisco, California $22.8M AUM

Partner Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Partner Investment Management held 103 positions worth $86.8M, down 18% from $105M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Partner Investment Management withdrew a net $21.3M in Q4 2017, closing 29 positions and reducing 25 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $2.37M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 49% of assets, up from 34% a quarter earlier, followed by Technology and Communication Services.

Against the trend, Partner Investment Management opened a new position in Allena Pharmaceuticals worth $4.72M.

  • Partner Investment Management's largest Q4 2017 buy was Allena Pharmaceuticals: 575,407 shares worth $4.72M.
  • Partner Investment Management added most to Puma Biotechnology in Q4 2017, an estimated $568K increase.
  • Partner Investment Management's biggest Q4 2017 reduction was Elevance Health, cutting an estimated $1.77M.
  • Partner Investment Management fully exited Meta Platforms (Facebook) in Q4 2017, selling an estimated $2.37M.
  • Partner Investment Management's ten largest holdings make up 35% of its $86.8M portfolio in Q4 2017.
  • Partner Investment Management opened 20 new positions and closed 29 in Q4 2017.
  • Partner Investment Management's portfolio value fell 18% quarter-over-quarter to $86.8M.

Based on Partner Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.